Literature DB >> 22439404

Combination of fertility preservation strategies in young women with recently diagnosed cancer.

M Huser1, J Zakova, L Smardova, I Crha, P Janku, R Hudecek, P Ventruba.   

Abstract

BACKGROUND/AIMS: The study describes clinical management and outcomes of currently available fertility preservation techniques in a set of 154 young female cancer patients.
METHODS: Patients in reproductive age with newly diagnosed cancer were offered embryo or oocyte cryopreservation, ovarian tissue cryopreservation and the administration of GnRH analogues during chemotherapy. Particular attention was given to the technical aspects and clinical application of these fertility preservation techniques.
RESULTS: During the study period (2004-2009), 154 young female cancer patients were offered fertility preservation counseling. Patient's average age was 29.4 years and average parity was 0.7 children. Administration of GnRH analogues (n = 123, 79.9%) and ovarian tissue cryopreservation (n = 15, 9.7%) were the most commonly used fertility preservation strategies. In 20 cases (16.1%), the combination of several fertility preservation techniques was offered to individually selected patients.
CONCLUSIONS: Combination of fertility preservation techniques gives young cancer patients the best chance for future fertility and should be concentrated in specialized centers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22439404

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues.

Authors:  M Huser; L Smardova; P Janku; I Crha; J Zakova; P Stourac; J Jarkovsky; J Mayer; P Ventruba
Journal:  J Assist Reprod Genet       Date:  2015-02-28       Impact factor: 3.412

Review 2.  Evidence-Based Recommendations for Fertility Preservation Options for Inclusion in Treatment Protocols for Pediatric and Adolescent Patients Diagnosed With Cancer.

Authors:  Alison Fernbach; Barbara Lockart; Cheryl L Armus; Lisa M Bashore; Jennifer Levine; Leah Kroon; Genevieve Sylvain; Cheryl Rodgers
Journal:  J Pediatr Oncol Nurs       Date:  2014-05-05       Impact factor: 1.636

3.  The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment.

Authors:  Seido Takae; Yodo Sugishita; Nobuhito Yoshioka; Mariko Hoshina; Yuki Horage; Yorino Sato; Chie Nishijima; Kazuhiro Kawamura; Nao Suzuki
Journal:  J Assist Reprod Genet       Date:  2014-12-03       Impact factor: 3.412

Review 4.  Fertility preservation in Hodgkin's lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era.

Authors:  Alexandra Traila; Patriciu Achimas-Cadariu; Delia Dima; Romeo Micu
Journal:  Cancer Manag Res       Date:  2018-06-13       Impact factor: 3.989

5.  Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval.

Authors:  Ralf Dittrich; Laura Lotz; Andreas Mueller; Inge Hoffmann; David L Wachter; Kerstin U Amann; Matthias W Beckmann; Thomas Hildebrandt
Journal:  Reprod Biol Endocrinol       Date:  2013-03-05       Impact factor: 5.211

Review 6.  Gene expression profiling of human oocytes developed and matured in vivo or in vitro.

Authors:  Irma Virant-Klun; Katja Knez; Tomaz Tomazevic; Thomas Skutella
Journal:  Biomed Res Int       Date:  2013-02-20       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.